Toshikazu Ushijima

43PUBLICATIONS
172CO-AUTHORS
Cancer diagnosisEpigenetics (incl. genome methylation and epigenomics)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Jul 10, 2026
ESRP1-regulated DNMT3B isoform switching determines the malignant potential of pancreatic cancer.

|Jul 03, 2026
EpiATLAS - a reference for human epigenomic research.

|May 03, 2026
Super-Enhancer Formation in Scirrhous Gastric CAFs, and the Presence of a Stromal Field in Non-Cancerous Tissues.

|Jan 27, 2026
Non-Clear Cell Renal Cell Carcinoma Has an Immune-Cold Phenotype That Affects Response to Immune Checkpoint Inhibitors.

Hiroki Ishihara, Yu-Yu Liu, Riu Yamashita

|Nov 13, 2025
Synthetic lethality of EZH2 and DNMT Inhibition suppresses neuroblastoma proliferation via MYCN destabilization.

Yuki Endo, Ryuichi P Sugino, Hisanori Takenobu

|Jun 18, 2025
How chronic inflammation fuels carcinogenesis as an environmental epimutagen.

Yu-Yu Liu, Yui Ohashi, Toshikazu Ushijima

Pageof 8

Frequent Collaborators

6 joint publications

Naoko Hattori

3 joint publications

Yu-Yu Liu

3 joint publications

Hiroshi Ureshino

2 joint publications

Nao Yoshida-Sakai